Cargando…
A Novel Dipeptidyl Peptidase-4 Inhibitor DA-1229 Ameliorates Tubulointerstitial Fibrosis in Cyclosporine Nephrotoxicity in Mice
Cyclosporine A (CyA) is an immunosuppressive agent that induces nephrotoxicity with long-term treatment. The roles of DPP-4 and its inhibitors in cyclosporine nephrotoxicity are not fully understood. Therefore, we investigated the effects of a novel DPP-4 inhibitor, DA-1229, on the progression of re...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8003165/ https://www.ncbi.nlm.nih.gov/pubmed/33803842 http://dx.doi.org/10.3390/life11030251 |
_version_ | 1783671625703489536 |
---|---|
author | Min, Hye Sook Lee, Ji Eun Ghee, Jung Yeon Kang, Young Sun Cha, Jin Joo Han, Jee Young Han, Sang Youb Cha, Dae Ryong |
author_facet | Min, Hye Sook Lee, Ji Eun Ghee, Jung Yeon Kang, Young Sun Cha, Jin Joo Han, Jee Young Han, Sang Youb Cha, Dae Ryong |
author_sort | Min, Hye Sook |
collection | PubMed |
description | Cyclosporine A (CyA) is an immunosuppressive agent that induces nephrotoxicity with long-term treatment. The roles of DPP-4 and its inhibitors in cyclosporine nephrotoxicity are not fully understood. Therefore, we investigated the effects of a novel DPP-4 inhibitor, DA-1229, on the progression of renal disease in an experimental cyclosporine nephrotoxicity model. Chronic cyclosporine nephrotoxicity was induced in six-week-old male ICR mice by subcutaneous injections of CyA at a dose of 30 mg/kg for four weeks. Animals were treated with DA-1229 at a dose of 300 mg/kg per day in food for four weeks. Although DPP-4 activity did not increase in the kidneys of mice with induced cyclosporine nephrotoxicity, DA-1229 treatment significantly suppressed DPP-4 activity in both plasma and renal tissues. DPP-4 inhibition by DA-1229 led to significantly decreased albuminuria and urinary excretion of 8-isoprosatane. DPP-4 inhibition also substantially suppressed pro-inflammatory effects, profibrotic molecules, and macrophage infiltration, and led to the improvement in renal structural changes. Our results suggest that DPP-4 inhibition by DA-1229 provides renoprotective effects in an animal model of cyclosporine nephrotoxicity via antioxidant, anti-inflammatory, and anti-fibrotic mechanisms. DPP-4 inhibition may be a useful new therapeutic approach for the management of progressive renal disease in cyclosporine nephrotoxicity. |
format | Online Article Text |
id | pubmed-8003165 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-80031652021-03-28 A Novel Dipeptidyl Peptidase-4 Inhibitor DA-1229 Ameliorates Tubulointerstitial Fibrosis in Cyclosporine Nephrotoxicity in Mice Min, Hye Sook Lee, Ji Eun Ghee, Jung Yeon Kang, Young Sun Cha, Jin Joo Han, Jee Young Han, Sang Youb Cha, Dae Ryong Life (Basel) Article Cyclosporine A (CyA) is an immunosuppressive agent that induces nephrotoxicity with long-term treatment. The roles of DPP-4 and its inhibitors in cyclosporine nephrotoxicity are not fully understood. Therefore, we investigated the effects of a novel DPP-4 inhibitor, DA-1229, on the progression of renal disease in an experimental cyclosporine nephrotoxicity model. Chronic cyclosporine nephrotoxicity was induced in six-week-old male ICR mice by subcutaneous injections of CyA at a dose of 30 mg/kg for four weeks. Animals were treated with DA-1229 at a dose of 300 mg/kg per day in food for four weeks. Although DPP-4 activity did not increase in the kidneys of mice with induced cyclosporine nephrotoxicity, DA-1229 treatment significantly suppressed DPP-4 activity in both plasma and renal tissues. DPP-4 inhibition by DA-1229 led to significantly decreased albuminuria and urinary excretion of 8-isoprosatane. DPP-4 inhibition also substantially suppressed pro-inflammatory effects, profibrotic molecules, and macrophage infiltration, and led to the improvement in renal structural changes. Our results suggest that DPP-4 inhibition by DA-1229 provides renoprotective effects in an animal model of cyclosporine nephrotoxicity via antioxidant, anti-inflammatory, and anti-fibrotic mechanisms. DPP-4 inhibition may be a useful new therapeutic approach for the management of progressive renal disease in cyclosporine nephrotoxicity. MDPI 2021-03-18 /pmc/articles/PMC8003165/ /pubmed/33803842 http://dx.doi.org/10.3390/life11030251 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ). |
spellingShingle | Article Min, Hye Sook Lee, Ji Eun Ghee, Jung Yeon Kang, Young Sun Cha, Jin Joo Han, Jee Young Han, Sang Youb Cha, Dae Ryong A Novel Dipeptidyl Peptidase-4 Inhibitor DA-1229 Ameliorates Tubulointerstitial Fibrosis in Cyclosporine Nephrotoxicity in Mice |
title | A Novel Dipeptidyl Peptidase-4 Inhibitor DA-1229 Ameliorates Tubulointerstitial Fibrosis in Cyclosporine Nephrotoxicity in Mice |
title_full | A Novel Dipeptidyl Peptidase-4 Inhibitor DA-1229 Ameliorates Tubulointerstitial Fibrosis in Cyclosporine Nephrotoxicity in Mice |
title_fullStr | A Novel Dipeptidyl Peptidase-4 Inhibitor DA-1229 Ameliorates Tubulointerstitial Fibrosis in Cyclosporine Nephrotoxicity in Mice |
title_full_unstemmed | A Novel Dipeptidyl Peptidase-4 Inhibitor DA-1229 Ameliorates Tubulointerstitial Fibrosis in Cyclosporine Nephrotoxicity in Mice |
title_short | A Novel Dipeptidyl Peptidase-4 Inhibitor DA-1229 Ameliorates Tubulointerstitial Fibrosis in Cyclosporine Nephrotoxicity in Mice |
title_sort | novel dipeptidyl peptidase-4 inhibitor da-1229 ameliorates tubulointerstitial fibrosis in cyclosporine nephrotoxicity in mice |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8003165/ https://www.ncbi.nlm.nih.gov/pubmed/33803842 http://dx.doi.org/10.3390/life11030251 |
work_keys_str_mv | AT minhyesook anoveldipeptidylpeptidase4inhibitorda1229amelioratestubulointerstitialfibrosisincyclosporinenephrotoxicityinmice AT leejieun anoveldipeptidylpeptidase4inhibitorda1229amelioratestubulointerstitialfibrosisincyclosporinenephrotoxicityinmice AT gheejungyeon anoveldipeptidylpeptidase4inhibitorda1229amelioratestubulointerstitialfibrosisincyclosporinenephrotoxicityinmice AT kangyoungsun anoveldipeptidylpeptidase4inhibitorda1229amelioratestubulointerstitialfibrosisincyclosporinenephrotoxicityinmice AT chajinjoo anoveldipeptidylpeptidase4inhibitorda1229amelioratestubulointerstitialfibrosisincyclosporinenephrotoxicityinmice AT hanjeeyoung anoveldipeptidylpeptidase4inhibitorda1229amelioratestubulointerstitialfibrosisincyclosporinenephrotoxicityinmice AT hansangyoub anoveldipeptidylpeptidase4inhibitorda1229amelioratestubulointerstitialfibrosisincyclosporinenephrotoxicityinmice AT chadaeryong anoveldipeptidylpeptidase4inhibitorda1229amelioratestubulointerstitialfibrosisincyclosporinenephrotoxicityinmice AT minhyesook noveldipeptidylpeptidase4inhibitorda1229amelioratestubulointerstitialfibrosisincyclosporinenephrotoxicityinmice AT leejieun noveldipeptidylpeptidase4inhibitorda1229amelioratestubulointerstitialfibrosisincyclosporinenephrotoxicityinmice AT gheejungyeon noveldipeptidylpeptidase4inhibitorda1229amelioratestubulointerstitialfibrosisincyclosporinenephrotoxicityinmice AT kangyoungsun noveldipeptidylpeptidase4inhibitorda1229amelioratestubulointerstitialfibrosisincyclosporinenephrotoxicityinmice AT chajinjoo noveldipeptidylpeptidase4inhibitorda1229amelioratestubulointerstitialfibrosisincyclosporinenephrotoxicityinmice AT hanjeeyoung noveldipeptidylpeptidase4inhibitorda1229amelioratestubulointerstitialfibrosisincyclosporinenephrotoxicityinmice AT hansangyoub noveldipeptidylpeptidase4inhibitorda1229amelioratestubulointerstitialfibrosisincyclosporinenephrotoxicityinmice AT chadaeryong noveldipeptidylpeptidase4inhibitorda1229amelioratestubulointerstitialfibrosisincyclosporinenephrotoxicityinmice |